Abstract
Background
Cyclooxygenase-2 (COX-2) catalyzes the formation of prostaglandins that contribute to the inflammation in atherosclerosis. The aim of the present study was to investigate the relationship between two polymorphisms (−1195G>A and -765G>C) in the COX-2 gene and subtypes of ischemic stroke in a Chinese population.
Methods
Genomic DNA of 224 patients with large artery atherosclerosis (LAA), 329 patients with small vessel occlusion (SVO), and 450 controls were genotyped for the COX-2 1195G>A (rs689466) and -765G>C (rs20417) polymorphisms using polymerase chain reaction–restriction fragment length polymorphism. Chi-square test and logistic regression analysis were performed for association analysis.
Results
The frequencies of variant allele with -1195G>A and -765G>C polymorphisms were 0.46 and 0.22, respectively. The -1195GA genotype and 1195A allele carriers were identified independently to be related with ischemic stroke (adjusted OR = 1.51, 95 % CI: 1.09–2.10, P = 0.02; OR = 1.45, 95 % CI: 1.06–1.97, P = 0.02) and SVO (adjusted OR = 1.57, 95 % CI: 1.07–2.30, P = 0.02; OR = 1.50, 95 % CI: 1.05–2.16, P = 0.03). In contrast, the 1195G>A polymorphism was not associated with LAA. No relationship between the -765G>C polymorphism and risk of either ischemic stroke was observed. The linkage disequilibrium analysis showed that -1195G>A and -765G>C SNPs are moderate linkage disequilibrium in this study population (D′ = 0.72, r 2 = 0.16). Compared with G-1195-G-765 haplotype, the haplotype of A-1195-G-765 showed significant increased risk of ischemic stroke (OR = 1.27, 95 % CI: 1.05–1.54, P = 0.02) and SVO (OR = 1.27, 95 % CI: 1.02–1.58, P = 0.03) but not LAA.
Conclusions
In conclusion, we found that -1195G>A polymorphism and A-1195-G-765 haplotype of COX-2 were associated with susceptibility to ischemic stroke in a Chinese population. The effects were confined to SVO among the stroke subtypes rather than to LAA.
Similar content being viewed by others
References
Adams HP Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35–41
Bonita R, Mendis S, Truelsen T, Bogousslavsky J, Toole J, Yatsu F (2004) The global stroke initiative. Lancet Neurol 3:391–393
Cipollone F, Fazia M, Iezzi A, Ciabattoni G, Pini B, Cuccurullo C, Ucchino S, Spigonardo F, De Luca M, Prontera C, Chiarelli F, Cuccurullo F, Mezzetti A (2004a) Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans. Arterioscler Thromb Vasc Biol 24:1259–1265
Cipollone F, Prontera C, Pini B, Marini M, Fazia M, De Cesare D, Iezzi A, Ucchino S, Boccoli G, Saba V, Chiarelli F, Cuccurullo F, Mezzetti A (2001) Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. Circulation 104:921–927
Cipollone F, Toniato E, Martinotti S, Fazia M, Iezzi A, Cuccurullo C, Pini B, Ursi S, Vitullo G, Averna M, Arca M, Montali A, Campagna F, Ucchino S, Spigonardo F, Taddei S, Virdis A, Ciabattoni G, Notarbartolo A, Cuccurullo F, Mezzetti A (2004b) A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. Jama 291:2221–2228
Colaizzo D, Fofi L, Tiscia G, Guglielmi R, Cocomazzi N, Prencipe M, Margaglione M, Toni D (2006) The COX-2 G/C −765 polymorphism may modulate the occurrence of cerebrovascular ischemia. Blood Coagul Fibrinolysis 17:93–96
de Vries HS, te Morsche RH, van Oijen MG, Nagtegaal ID, Peters WH, de Jong DJ (2010) The functional -765G–>C polymorphism of the COX-2 gene may reduce the risk of developing Crohn's disease. PLoS One 5:e15011
Dichgans M, Markus HS (2005) Genetic association studies in stroke: methodological issues and proposed standard criteria. Stroke 36:2027–2031
Hao Y (2009) Study on relationship between cyclooxygenase 2 gene haplotypes and atherosclerotic ischemic stroke in Chinese Han population In: Master's degree thesis of Shandong University, vol. Master, p 53 Shandong, China: Shandong University
Hassan A, Markus HS (2000) Genetics and ischaemic stroke. Brain 123(Pt 9):1784–1812
Jerrard-Dunne P, Cloud G, Hassan A, Markus HS (2003) Evaluating the genetic component of ischemic stroke subtypes: a family history study. Stroke 34:1364–1369
Kim Y, Lee C (2006) The gene encoding transforming growth factor beta 1 confers risk of ischemic stroke and vascular dementia. Stroke 37:2843–2845
Kohsaka S, Volcik KA, Folsom AR, Wu KK, Ballantyne CM, Willerson JT, Boerwinkle E (2008) Increased risk of incident stroke associated with the cyclooxygenase 2 (COX-2) G-765C polymorphism in African-Americans: the Atherosclerosis Risk in Communities Study. Atherosclerosis 196:926–930
Lee C, Kong M (2007) (An interactive association of common sequence variants in the neuropeptide Y gene with susceptibility to ischemic stroke. Stroke; A J of Cereb Circ 38:2663–2669
Lee CR, North KE, Bray MS, Couper DJ, Heiss G, Zeldin DC (2008) Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study. Clin Pharmacol Ther 83:52–60
Lemaitre RN, Rice K, Marciante K, Bis JC, Lumley TS, Wiggins KL, Smith NL, Heckbert SR, Psaty BM (2009) Variation in eicosanoid genes, non-fatal myocardial infarction and ischemic stroke. Atherosclerosis 204:e58–63
Lester PA, Diaz JA, Shuster KA, Henke PK, Wakefield TW, Myers DD (2012) Inflammation and thrombosis: new insights. Frontiers in Biosci(Scholar edition) 4:620–638
Libby P (2002) Inflammation in atherosclerosis. Nature 420:868–874
Orbe J, Beloqui O, Rodriguez JA, Belzunce MS, Roncal C, Paramo JA (2006) Protective effect of the G-765C COX-2 polymorphism on subclinical atherosclerosis and inflammatory markers in asymptomatic subjects with cardiovascular risk factors. Clin Chim Acta 368:138–143
Papafili A, Hill MR, Brull DJ, McAnulty RJ, Marshall RP, Humphries SE, Laurent GJ (2002) Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol 22:1631–1636
Pezzini A, Grassi M, Del Zotto E, Archetti S, Spezi R, Vergani V, Assanelli D, Caimi L, Padovani A (2005) Cumulative effect of predisposing genotypes and their interaction with modifiable factors on the risk of ischemic stroke in young adults. Stroke; A J of Cereb Circ 36:533–539
Rudock ME, Liu Y, Ziegler JT, Allen SG, Lehtinen AB, Freedman BI, Carr JJ, Langefeld CD, Bowden DW (2009) Association of polymorphisms in cyclooxygenase (COX)-2 with coronary and carotid calcium in the Diabetes Heart Study. Atherosclerosis 203:459–465
Talar-Wojnarowska R, Gasiorowska A, Olakowski M, Lampe P, Smolarz B, Romanowicz-Makowska H, Malecka-Panas E (2011) Role of cyclooxygenase-2 gene polymorphisms in pancreatic carcinogenesis. World J Gastroenterol 17:4113–4117
Tao HM, Chen GZ (2009) Endothelial NO synthase gene polymorphisms and risk of ischemic stroke: a meta-analysis. Neurosci Res 64:311–316
Tao HM, Chen GZ, Cheng GP, Shan XY (2012) The haplotype of the TGFbeta1 gene associated with cerebral infarction in Chinese. Can J Neurol Sci 39:626–631
Tay A, Squire JA, Goldberg H, Skorecki K (1994) Assignment of the human prostaglandin-endoperoxide synthase 2 (PTGS2) gene to 1q25 by fluorescence in situ hybridization. Genomics 23:718–719
Vane JR, Bakhle YS, Botting RM (1998) Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38:97–120
Wang F (2007) Genetic research into cerebral infarction-associated gene In: the First Affiliated Hospital, vol. PhD thesis, p 108 Changchun: Jilin University
Warner TD, Mitchell JA (2004) Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J 18:790–804
Xie C, Yao MZ, Liu JB, Xiong LK (2011) A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia. Cytokine 56:550–559
Zhang X, Miao X, Tan W, Ning B, Liu Z, Hong Y, Song W, Guo Y, Zhang X, Shen Y, Qiang B, Kadlubar FF, Lin D (2005) Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology 129:565–576
Source of funding
This study was supported by a grant of the Jinhua Science and Technology Bureau project, Zhejiang Province, the people's republic of china (No: 2008-3-055).
Conflicts of interest
The authors declare that there is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, Gz., Shan, Xy., Cheng, Gp. et al. Cyclooxygenase-2 Genetic Polymorphism and Stroke Subtypes in Chinese. J Mol Neurosci 51, 467–473 (2013). https://doi.org/10.1007/s12031-013-0078-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-013-0078-5